Brokers Offer Predictions for Varex Imaging Corp’s FY2020 Earnings (NASDAQ:VREX)

Share on StockTwits

Varex Imaging Corp (NASDAQ:VREX) – Equities research analysts at Jefferies Financial Group dropped their FY2020 EPS estimates for shares of Varex Imaging in a note issued to investors on Monday, August 12th. Jefferies Financial Group analyst A. Petrone now forecasts that the company will post earnings of $1.31 per share for the year, down from their previous estimate of $1.40. Jefferies Financial Group currently has a “Buy” rating and a $31.00 target price on the stock. Jefferies Financial Group also issued estimates for Varex Imaging’s FY2021 earnings at $1.45 EPS and FY2022 earnings at $1.65 EPS.

Varex Imaging (NASDAQ:VREX) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $0.24 earnings per share for the quarter, missing analysts’ consensus estimates of $0.31 by ($0.07). The company had revenue of $196.70 million for the quarter, compared to the consensus estimate of $189.42 million. Varex Imaging had a net margin of 0.97% and a return on equity of 10.01%. Varex Imaging’s revenue for the quarter was up 2.9% compared to the same quarter last year. During the same period in the previous year, the business earned $0.34 EPS.

Several other brokerages also recently weighed in on VREX. CJS Securities raised Varex Imaging from a “market perform” rating to an “outperform” rating in a report on Tuesday, June 11th. Northland Securities reissued a “buy” rating and issued a $42.00 price target on shares of Varex Imaging in a report on Wednesday, August 7th. Finally, Zacks Investment Research cut Varex Imaging from a “buy” rating to a “hold” rating in a research note on Saturday, June 15th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Varex Imaging currently has an average rating of “Buy” and a consensus target price of $34.20.

Shares of NASDAQ VREX opened at $25.54 on Wednesday. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.04 and a current ratio of 2.58. The company has a market cap of $996.48 million, a PE ratio of 19.65, a P/E/G ratio of 1.94 and a beta of 1.80. The business has a 50-day simple moving average of $30.00 and a two-hundred day simple moving average of $30.83. Varex Imaging has a fifty-two week low of $21.57 and a fifty-two week high of $35.00.

In other news, SVP Kimberley E. Honeysett sold 916 shares of the firm’s stock in a transaction dated Wednesday, June 26th. The stock was sold at an average price of $30.00, for a total value of $27,480.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Kevin Bruce Yankton sold 1,149 shares of the firm’s stock in a transaction dated Monday, July 15th. The stock was sold at an average price of $31.00, for a total value of $35,619.00. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 2,333 shares of company stock valued at $71,289. Company insiders own 2.40% of the company’s stock.

Several large investors have recently made changes to their positions in the company. Public Employees Retirement System of Ohio raised its position in Varex Imaging by 62.6% during the fourth quarter. Public Employees Retirement System of Ohio now owns 1,849 shares of the company’s stock valued at $44,000 after acquiring an additional 712 shares in the last quarter. Quadrant Capital Group LLC raised its position in Varex Imaging by 478.6% during the first quarter. Quadrant Capital Group LLC now owns 1,678 shares of the company’s stock valued at $55,000 after acquiring an additional 1,388 shares in the last quarter. Wealth Architects LLC purchased a new position in Varex Imaging during the first quarter valued at approximately $206,000. Magnus Financial Group LLC purchased a new position in Varex Imaging during the first quarter valued at approximately $209,000. Finally, Janney Montgomery Scott LLC purchased a new position in Varex Imaging during the first quarter valued at approximately $212,000. Hedge funds and other institutional investors own 89.65% of the company’s stock.

About Varex Imaging

Varex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, ionization chambers, and buckys.

Recommended Story: What Is An Exchange-Traded Fund (ETF)?

Earnings History and Estimates for Varex Imaging (NASDAQ:VREX)

Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

ACADIA Pharmaceuticals  Lifted to “Outperform” at Leerink Swann
ACADIA Pharmaceuticals Lifted to “Outperform” at Leerink Swann
Agios Pharmaceuticals  Lifted to Sell at BidaskClub
Agios Pharmaceuticals Lifted to Sell at BidaskClub
Axcelis Technologies  Upgraded to Buy by BidaskClub
Axcelis Technologies Upgraded to Buy by BidaskClub
Achillion Pharmaceuticals  Rating Lowered to Sell at ValuEngine
Achillion Pharmaceuticals Rating Lowered to Sell at ValuEngine
Apple  Price Target Cut to $165.00
Apple Price Target Cut to $165.00
ACADIA Pharmaceuticals  Upgraded to “Outperform” by Svb Leerink
ACADIA Pharmaceuticals Upgraded to “Outperform” by Svb Leerink


© 2006-2019 Ticker Report